Eye cancer treatment with immunotherapy

The immune system plays a significant role in fighting cancer. It typically helps to detect, reach, and eliminate cancerous cells all over the body. Eye cancer isn’t an exception, and patients with eye tumors also might benefit significantly from activating their immune systems. So that’s why medical practitioners have started to use different methods of immunotherapy to increase and enhance the immune response of patients with eye cancer to achieve better treatment results. Most often, immunotherapy prescribes as an additional method of treatment that aims to increase the efficiency of other therapies. Still, sometimes it might be used as a primary or even a single treatment method. It depends on the type of cancer, stage, grade, and patient’s health condition. There are dozens of available medications for immunotherapy of patients with eye cancer, including ebentafusp-tebn, a new drug that the FDA recently approved. Immunotherapy mostly delivers via droppers or intravenous injections and takes up to a few hours. A single course of immunotherapy typically takes many sessions. Patients should take a few courses of immunotherapy to start noticing sustainable improvements in their condition.